Lipopolysaccharide signaling in endothelial cells (Q36343571)

13 August 2017

1 reference

title

Lipopolysaccharide signaling in endothelial cells (English)

1 reference

13 August 2017

0 references

0 references

Shauna M Dauphinee

1

1 reference

13 August 2017

Aly Karsan

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2006

1 reference

13 August 2017

published in

Laboratory Investigation

1 reference

13 August 2017

volume

86

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

9-22

1 reference

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Dysregulation of the immune response in severe sepsis

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Toll-like receptors and innate immunity

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Cell biology of endothelial cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Endothelial responses to bacterial toxins in sepsis.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Endothelium function in sepsis

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Cells in focus: endothelial cell

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Role of endogenous nitric oxide in endotoxin-induced alteration of hypoxic pulmonary vasoconstriction in mice

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Nitric oxide and septic shock

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Protein kinase signaling in the modulation of microvascular permeability

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Endotoxin-Neutralizing Protein Protects against Endotoxin-Induced Endothelial Barrier Dysfunction

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

The complexities of leukocyte recruitment

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

LPS tolerance in human endothelial cells: reduced PMN adhesion, E-selectin expression, and NF-kappaB mobilization

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Mice genetically lacking endothelial selectins are resistant to the lethality in septic peritonitis.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Role of endothelium in thrombosis and hemostasis

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

The anticoagulant protein C pathway

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Transcriptional regulation of tissue factor expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

The endothelium in sepsis: source of and a target for inflammation

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Structure and function of lipopolysaccharide binding protein

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TLR4 is the signaling but not the lipopolysaccharide uptake receptor

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Synthesis and surface expression of CD14 by human endothelial cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Essential role of MD-2 in LPS responsiveness and TLR4 distribution

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

A CD14-independent LPS receptor cluster

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Intracellular Recognition of Lipopolysaccharide by Toll-like Receptor 4 in Intestinal Epithelial Cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Integrin-nucleated Toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Cytoplasmic domain-mediated dimerizations of toll-like receptor 4 observed by beta-lactamase enzyme fragment complementation

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TLR signaling pathways

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TIRAP mediates endotoxin-induced NF-kappaB activation and apoptosis in endothelial cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TRAF6 is a signal transducer for interleukin-1

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TAK1-binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the IL-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TAB3, a new binding partner of the protein kinase TAK1

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

The Interleukin-1 Receptor-associated Kinase Is Degraded by Proteasomes following Its Phosphorylation

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Ubiquitin activated tumor necrosis factor receptor associated factor-6 (TRAF6) is recycled via deubiquitination

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lipopolysaccharide-induced NF-kappaB activation in human endothelial cells involves degradation of IkappaBalpha but not IkappaBbeta

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Involvement of PKCα/β in TLR4 and TLR2 dependent activation of NF-κB

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

A role for PKCzeta in the LPS-induced translocation NF-kappaB p65 subunit in cultured myometrial cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Structure and function of phosphoinositide 3-kinases.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lipopolysaccharide initiates a TRAF6-mediated endothelial survival signal

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

RIP links TLR4 to Akt and is essential for cell survival in response to LPS stimulation

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Involvement of receptor-interacting protein 2 in innate and adaptive immune responses

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Participation of Rip2 in lipopolysaccharide signaling is independent of its kinase activity

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lipopolysaccharide signals an endothelial apoptosis pathway through TNF receptor-associated factor 6-mediated activation of c-Jun NH2-terminal kinase

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

JNK-interacting protein 3 associates with Toll-like receptor 4 and is involved in LPS-mediated JNK activation

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-Kinase and Syk-mediated pathways

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-κB and c-Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Unresponsiveness of MyD88-deficient mice to endotoxin

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

IRF family of transcription factors as regulators of host defense

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Mastoparan, a G protein agonist peptide, differentially modulates TLR4- and TLR2-mediated signaling in human endothelial cells and murine macrophages

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Pleckstrin homology and phosphotyrosine-binding domain-dependent membrane association and tyrosine phosphorylation of Dok-4, an inhibitory adapter molecule expressed in epithelial cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Mitochondrial Dok-4 recruits Src kinase and regulates NF-kappaB activation in endothelial cells.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

PI3K-mediated negative feedback regulation of IL-12 production in DCs

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Expression of a constitutively active form of phosphatidylinositol 3-kinase inhibits the induction of nitric oxide synthase in human astrocytes

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Regulation of Toll-like receptor 4 signalling by A20 zinc finger protein

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

A1 is a constitutive and inducible Bcl-2 homologue in mature human neutrophils

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

The BH4 domain of A1, an anti-apoptotic bcl family gene, is necessary and sufficient for its antiinflammatory function in endothelial cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

The apoptotic signaling pathway activated by Toll-like receptor-2

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Negative regulation of toll-like receptor-mediated signaling by Tollip

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

https://api.crossref.org/works/10.1038/LABINVEST.3700366

1 reference

7 January 2021

p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

LPS-Induced Upregulation of SHIP Is Essential for Endotoxin Tolerance

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

A novel negative regulator for IL-1 receptor and Toll-like receptor 4.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Negative regulation of cytokine signaling and immune responses by SOCS proteins

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

SOCS-1 participates in negative regulation of LPS responses

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

SOCS1/JAB is a negative regulator of LPS-induced macrophage activation

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Fetal plasma stimulates endothelial cell production of cytokines and the family of suppressor of cytokine signaling in umbilical placental vascular disease

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Possible involvement of toll-like receptor 4 in endothelial cell activation of larger vessels in response to lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Selective suppression of Toll-like receptor 4 activation by chemokine receptor 4.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Cxc chemokine receptor expression on human endothelial cells

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

IRAK-M is a negative regulator of Toll-like receptor signaling

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling.

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700366

7 January 2021

10.1038/LABINVEST.3700366

Identifiers

DOI

1 reference

Dimensions Publication ID

13 August 2017

1045144391

0 references

1 reference